Review
World J Hematol
2(3):62-70.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.62
Abstract (2790)
|
Core Tip (2000)
|
Full Article (HTML) (57561)
|
Figures (1-9) (1688)
|
Full Article (PDF)-576K (2580)
|
Peer-Review Report-178K (514)
|
Answering Reviewers-107K (499)
|
Received: 04/01/2013
|
Revised: 05/14/2013
|
Accepted: 06/10/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (72489)
|
Similar Articles (16)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms
World J Hematol
2(3):71-88.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.71
Abstract (2061)
|
Core Tip (1779)
|
Full Article (HTML) (10703)
|
Figures (1-10) (694)
|
Tables (1-6) (593)
|
Full Article (PDF)-3685K (1075)
|
Peer-Review Report-98K (505)
|
Answering Reviewers-50K (409)
|
Received: 01/11/2013
|
Accepted: 06/18/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (21291)
|
Similar Articles (5)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hematol
2(3):89-98.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.89
Abstract (2026)
|
Core Tip (1700)
|
Full Article (HTML) (9006)
|
Figures (1-6) (642)
|
Tables (1-2) (430)
|
Full Article (PDF)-1438K (833)
|
Peer-Review Report-192K (316)
|
Answering Reviewers-63K (349)
|
Received: 03/11/2013
|
Revised: 05/10/2013
|
Accepted: 06/06/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (18861)
|
Similar Articles (34)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
